Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07163858

Postural Mobilization Compared to Noradrenaline Only in Off-Pump CABG Surgery

Comparison of Hemodynamic Management by Postural Mobilization Versus Chemical Vasoconstriction Using Noradrenaline Exclusively in Off-pump Coronary Artery Bypass Graft Surgery: A Prospective, Randomized, Comparative, Single-center Study.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Infirmerie Protestante de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This interventional prospective randomized study is designed to compare hemodynamic management using postural mobilization (+/- noradrenaline) versus noradrenaline only in patients undergoing open-heart coronary artery bypass graft (CABG) surgery.

Detailed description

OPTICAB is a single-site study in France that aims to compare two hemodynamic management techniques during off-pump coronary artery bypass graft (CABG) surgery: postural mobilization (+/- noradrenaline) versus noradrenaline only. Primary objective is to evaluate how often noradrenaline is needed when managing hemodynamics using postural mobilization (passive leg raising) during off-pump CABG surgery. The study will also compare revascularization rate and post-operative complications among both groups, and assess perioperative hemodynamic management during the 30-day follow up period.

Conditions

Interventions

TypeNameDescription
PROCEDUREpassive leg raising for hemodynamic management during open-heart coronary bypass graftingPassive leg raising will be used in the experimental group in order to manage hemodynamics: legs will be raised to an angle of approx. 45°
PROCEDUREUse of Noradrenaline only in control groupNoradrenaline will be used for hemodynamic management. Passive leg raising will not be used in this group

Timeline

Start date
2025-10-06
Primary completion
2027-07-01
Completion
2027-08-01
First posted
2025-09-09
Last updated
2025-12-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07163858. Inclusion in this directory is not an endorsement.